USD 1.48 billion
Targeted Liposomes Drug Delivery Market Size, Share, Growth Analysis, By Type of Liposomes(PEGylated Liposomes, Cationic Liposomes, Anionic Liposomes, and Neutral Liposomes), By Application(Cancer Therapy, Infectious Disease Treatment, Ophthalmological Treatment, Cardiovascular Disease Treatment), By Targeted Drug Type(Chemotherapy Drugs, Antifungal Drugs, Antibiotic Drugs, Immunomodulatory Drugs), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2300 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|Tables:
95
|Figures:
76
Targeted Liposomes Drug Delivery Market Insights
Targeted Liposomes Drug Delivery Market size was valued at USD 1.55 Billion in 2023 and is poised to grow from USD 1.62 Billion in 2024 to USD 2.3 Billion by 2032, growing at a CAGR of 4.5% during the forecast period (2025-2032).
The global Targeted Liposomes Drug Delivery Market is experiencing significant increase pushed by way of improvements in drug shipping technologies. Targeted liposomes provide specific and controlled drug release, reducing facet consequences and improving therapeutic efficacy. Increasing incidence of chronic illnesses and a developing demand for customized medication contribute to the market's expansion. Additionally, ongoing studies and improvement activities, strategic collaborations, and a surge in investment in healthcare in addition propel the marketplace. North America and Europe lead in marketplace proportion because of strong healthcare infrastructure, at the same time as the Asia-Pacific vicinity provides rewarding opportunities with a growing recognition on healthcare advancements and increasing affected person populace. Key trends consist of the development of novel formulations and the exploration of focused therapies, indicating a dynamic and evolving landscape inside the Targeted Liposomes Drug Delivery Market.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
PEGylated Liposomes
Fastest Growth
PEGylated Liposomes
Growth Rate
4.5% CAGR
Global Targeted Liposomes Drug Delivery Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Targeted Liposomes Drug Delivery Market Segmental Analysis
The global Targeted Liposomes Drug Delivery market is segmented into four major segments i.e. by By Type of Liposomes, Application, Targeted Drug Type, and region. Based on Type, it is divided into PEGylated Liposomes, Cationic Liposomes, Anionic Liposomes, Neutral Liposomes. Based on Application, it is bifurcated as Cancer Therapy, Infectious Disease Treatment, Ophthalmological Treatment, Cardiovascular Disease Treatment, Other Therapeutic Areas. Based on Targeted Drug Type it is segregated into, Chemotherapy Drugs, Antifungal Drugs, Antibiotic Drugs, Immunomodulatory Drugs, Other Drug Types. Based on region, the market is segmented into United States, Canada, and Mexico.
Analysis by Type
PEGylation imparts increased balance to liposomes, extending their stream time in the bloodstream and improving drug transport efficiency. It reduces the immunogenicity of liposomes, minimizing the threat of immune gadget recognition and clearance. PEGylated liposomes locate widespread programs in numerous healing regions, such as cancer therapy, because of their versatility and efficacy.
Cationic liposomes are mainly effective in gene shipping programs, contributing to the developing discipline of gene remedy. The potential of cationic liposomes to successfully encapsulate and deliver genetic material makes them important within the improvement of personalized medicinal drugs. Ongoing research and advancements in genetic and nucleic acid-based total therapies make a contribution to the growing demand for cationic liposomes.
Analysis by Application
Cancer is a main motive of morbidity and mortality globally, driving the demand for powerful drug shipping structures like focused liposomes. Extensive studies in oncology and the development of novel cancer therapeutics make a contribution to the prominence of liposomes in cancer remedy. Liposomes provide targeted drug shipping to cancer cells, minimizing harm to healthy tissues and enhancing remedy consequences.
The growing incidence of infectious illnesses, along with viral and bacterial infections, fuels the demand for green drug shipping structures. Recent international activities, along with the COVID-19 pandemic, spotlight the need for superior drug shipping strategies for infectious disorder control. Ongoing research on liposomal formulations for antiviral and antibacterial tablets contributes to the section's rapid increase.
Global Targeted Liposomes Drug Delivery Market By Type of liposomes
To get detailed analysis on other segments, Request For Free Sample Report
Targeted Liposomes Drug Delivery Market Regional Insights
North America boasts superior healthcare infrastructure, facilitating full-size adoption of revolutionary drug delivery technology. Extensive investments in research and development make contributions to the creation of novel liposomal formulations and therapeutic procedures. The excessive occurrence of persistent diseases, especially cancer, drives the call for centered liposome drug shipping within the area.
Rising healthcare expenditure in nations like China and India helps the improvement and adoption of superior drug shipping technologies. The full-size and developing patient populace inside the area contributes to accelerated demand for centered liposomes in numerous therapeutic areas. Government tasks aimed at improving healthcare infrastructure and promoting research and improvement similarly propel marketplace increase inside the Asia-Pacific region.
Global Targeted Liposomes Drug Delivery Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Targeted Liposomes Drug Delivery Market Dynamics
Drivers
Increasing Demand for Personalized and Precision Medicine
- The growing demand for personalized and precision medicinal drugs, in which focused liposomes play a pivotal role. These drug delivery motors offer unique and managed launch, minimizing side consequences and improving healing efficacy. The escalating occurrence of persistent sicknesses, especially most cancers, has led to an augmented awareness of superior drug delivery technologies like targeted liposomes.
Restraints
High Cost Associated with Advanced Liposomal Formulations
- One of the primary market restraints is the high fee related to advanced liposomal formulations and technologies, which may also pose a mission to significant accessibility. Regulatory complexities and ranging approval tactics across specific regions additionally contribute to the constraints, doubtlessly delaying the creation of latest liposomal merchandise to the market.
Request Free Customization of this report to help us to meet your business objectives.
Targeted Liposomes Drug Delivery Market Competitive Landscape
The competitive surroundings of the Targeted Liposomes Drug Delivery marketplace is dynamic and characterized by the presence of established players and rising organizations striving for market prominence. The agencies engage in strategic initiatives like mergers, acquisitions, and collaborations to bolster their marketplace role. Concurrently, smaller and area of interest gamers focus on specialised liposomal formulations, contributing to market variety.
Top Player’s Company Profiles
- Alnylam Pharmaceuticals
- Acuity Pharmaceuticals, Inc.
- Jubilant Therapeutics
- Verifor Pharmaceuticals
- BIND Therapeutics
- Paladin Labs
- Lipo Therapeutics
- Pharming Group N.V.
- Johnson & Johnson Services, Inc.
- Gilead Sciences, Inc.
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Janssen Pharmaceuticals, Inc.
- CELSION Corporation
- Abbott
- Ipsen Pharma
- Spectrum Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Roche Holding AG
Recent Developments
- July 2023: PEGylated liposomes incorporating the CREKA concentrated on moiety are diagnosed recovery dealers, particularly in experimental fashions with excessive metastatic capability. CREKA is uniquely centered on the tumor-related extracellular matrix (ECM) determined in each primary and metastatic tumor location. To gain a deeper insight into the capability of these centered on moieties, we opted to create numerous liposome formulations with diverse portions of the concentrated moiety connected to their DSPE-PEG molecules.
Targeted Liposomes Drug Delivery Key Market Trends
- Rising Focus on Personalized Medicine: Rising Focus On Personalized Medicine: The heightened interest on personalized medication, the usage of the customization of liposomal formulations for individual affected character desires. The non-forestall innovation in liposomal generation, together with the development of smart and stimuli-responsive liposomes, shows the enterprise's self-control to improve drug shipping precision.
Targeted Liposomes Drug Delivery Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global Targeted Liposomes Drug Delivery marketplace analysis famous for a dynamic market with a number of standout tendencies and problems. The market is propelled by the rising call for precision medicinal drugs and improvements in liposomal technologies. However, economic constraints and regulatory complexities avoid massive accessibility. PEGylated liposomes dominate, pushed with the aid of improved balance. North America leads due to superior healthcare infrastructure, whilst the Asia-Pacific location reports fast growth with increasing healthcare expenditure. Key traits encompass personalized medication awareness, innovation in liposomal technologies, and exploration of combination treatment options, reflecting a dynamic landscape dedicated to improving drug delivery precision and healing results.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.55 Billion |
| Market size value in 2032 | USD 2.3 Billion |
| Growth Rate | 4.5% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Targeted Liposomes Drug Delivery Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Targeted Liposomes Drug Delivery Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Targeted Liposomes Drug Delivery Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Targeted Liposomes Drug Delivery Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Targeted Liposomes Drug Delivery Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Targeted Liposomes Drug Delivery Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
